PHOTRONICS INC (PLAB) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:PLAB • US7194051022

34.39 USD
+0.46 (+1.36%)
At close: Feb 5, 2026
33.64 USD
-0.75 (-2.18%)
After Hours: 2/5/2026, 8:00:01 PM
Fundamental Rating

6

Overall PLAB gets a fundamental rating of 6 out of 10. We evaluated PLAB against 113 industry peers in the Semiconductors & Semiconductor Equipment industry. PLAB gets an excellent profitability rating and is at the same time showing great financial health properties. PLAB has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • PLAB had positive earnings in the past year.
  • In the past year PLAB had a positive cash flow from operations.
  • Each year in the past 5 years PLAB has been profitable.
  • PLAB had a positive operating cash flow in each of the past 5 years.
PLAB Yearly Net Income VS EBIT VS OCF VS FCFPLAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 7.56%, PLAB is in the better half of the industry, outperforming 73.45% of the companies in the same industry.
  • PLAB has a Return On Equity of 11.62%. This is in the better half of the industry: PLAB outperforms 76.11% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 10.17%, PLAB is in the better half of the industry, outperforming 79.65% of the companies in the same industry.
  • PLAB had an Average Return On Invested Capital over the past 3 years of 12.29%. This is in line with the industry average of 10.71%.
Industry RankSector Rank
ROA 7.56%
ROE 11.62%
ROIC 10.17%
ROA(3y)7.8%
ROA(5y)7.34%
ROE(3y)12.05%
ROE(5y)11.43%
ROIC(3y)12.29%
ROIC(5y)11.75%
PLAB Yearly ROA, ROE, ROICPLAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • PLAB's Profit Margin of 16.06% is fine compared to the rest of the industry. PLAB outperforms 74.34% of its industry peers.
  • PLAB's Profit Margin has improved in the last couple of years.
  • With an excellent Operating Margin value of 24.51%, PLAB belongs to the best of the industry, outperforming 82.30% of the companies in the same industry.
  • PLAB's Operating Margin has improved in the last couple of years.
  • With a Gross Margin value of 35.30%, PLAB is not doing good in the industry: 62.83% of the companies in the same industry are doing better.
  • PLAB's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 24.51%
PM (TTM) 16.06%
GM 35.3%
OM growth 3Y-1.57%
OM growth 5Y18.52%
PM growth 3Y3.68%
PM growth 5Y23.71%
GM growth 3Y-0.36%
GM growth 5Y9.83%
PLAB Yearly Profit, Operating, Gross MarginsPLAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), PLAB is creating some value.
  • PLAB has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for PLAB has been reduced compared to 5 years ago.
  • PLAB has a better debt/assets ratio than last year.
PLAB Yearly Shares OutstandingPLAB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
PLAB Yearly Total Debt VS Total AssetsPLAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 3.84 indicates that PLAB is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.84, PLAB is in line with its industry, outperforming 53.98% of the companies in the same industry.
  • The Debt to FCF ratio of PLAB is 0.00, which is an excellent value as it means it would take PLAB, only 0.00 years of fcf income to pay off all of its debts.
  • PLAB has a Debt to FCF ratio of 0.00. This is amongst the best in the industry. PLAB outperforms 86.73% of its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that PLAB is not too dependend on debt financing.
  • PLAB has a better Debt to Equity ratio (0.00) than 74.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.84
ROIC/WACC0.93
WACC10.98%
PLAB Yearly LT Debt VS Equity VS FCFPLAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • PLAB has a Current Ratio of 5.37. This indicates that PLAB is financially healthy and has no problem in meeting its short term obligations.
  • PLAB has a Current ratio of 5.37. This is in the better half of the industry: PLAB outperforms 76.11% of its industry peers.
  • A Quick Ratio of 4.99 indicates that PLAB has no problem at all paying its short term obligations.
  • PLAB has a better Quick ratio (4.99) than 79.65% of its industry peers.
Industry RankSector Rank
Current Ratio 5.37
Quick Ratio 4.99
PLAB Yearly Current Assets VS Current LiabilitesPLAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • PLAB shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.53%.
  • Measured over the past years, PLAB shows a very strong growth in Earnings Per Share. The EPS has been growing by 30.81% on average per year.
  • Looking at the last year, PLAB shows a decrease in Revenue. The Revenue has decreased by -2.04% in the last year.
  • PLAB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.85% yearly.
EPS 1Y (TTM)2.53%
EPS 3Y0.83%
EPS 5Y30.81%
EPS Q2Q%1.69%
Revenue 1Y (TTM)-2.04%
Revenue growth 3Y0.99%
Revenue growth 5Y6.85%
Sales Q2Q%-3.08%

3.2 Future

  • Based on estimates for the next years, PLAB will show a small growth in Earnings Per Share. The EPS will grow by 5.62% on average per year.
  • The Revenue is expected to grow by 6.23% on average over the next years.
EPS Next Y7.02%
EPS Next 2Y5.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.7%
Revenue Next 2Y6.23%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
PLAB Yearly Revenue VS EstimatesPLAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
PLAB Yearly EPS VS EstimatesPLAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 16.94, the valuation of PLAB can be described as correct.
  • Compared to the rest of the industry, the Price/Earnings ratio of PLAB indicates a rather cheap valuation: PLAB is cheaper than 94.69% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of PLAB to the average of the S&P500 Index (27.67), we can say PLAB is valued slightly cheaper.
  • A Price/Forward Earnings ratio of 15.83 indicates a correct valuation of PLAB.
  • Based on the Price/Forward Earnings ratio, PLAB is valued cheaper than 92.04% of the companies in the same industry.
  • PLAB's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.20.
Industry RankSector Rank
PE 16.94
Fwd PE 15.83
PLAB Price Earnings VS Forward Price EarningsPLAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, PLAB is valued cheaper than 99.11% of the companies in the same industry.
  • 83.19% of the companies in the same industry are more expensive than PLAB, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 34.06
EV/EBITDA 4.61
PLAB Per share dataPLAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PLAB does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of PLAB may justify a higher PE ratio.
PEG (NY)2.41
PEG (5Y)0.55
EPS Next 2Y5.62%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for PLAB!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PHOTRONICS INC

NASDAQ:PLAB (2/5/2026, 8:00:01 PM)

After market: 33.64 -0.75 (-2.18%)

34.39

+0.46 (+1.36%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)12-10
Earnings (Next)02-25
Inst Owners94.12%
Inst Owner Change-1.41%
Ins Owners3.91%
Ins Owner Change-0.12%
Market Cap2.03B
Revenue(TTM)849.29M
Net Income(TTM)136.40M
Analysts84.44
Price Target43.2 (25.62%)
Short Float %5.74%
Short Ratio2.1
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.53%
Min EPS beat(2)29.38%
Max EPS beat(2)31.69%
EPS beat(4)3
Avg EPS beat(4)12.6%
Min EPS beat(4)-19.14%
Max EPS beat(4)31.69%
EPS beat(8)4
Avg EPS beat(8)2.09%
EPS beat(12)6
Avg EPS beat(12)2.67%
EPS beat(16)9
Avg EPS beat(16)6.93%
Revenue beat(2)2
Avg Revenue beat(2)1.95%
Min Revenue beat(2)0.82%
Max Revenue beat(2)3.08%
Revenue beat(4)2
Avg Revenue beat(4)0.12%
Min Revenue beat(4)-2.46%
Max Revenue beat(4)3.08%
Revenue beat(8)3
Avg Revenue beat(8)-2.37%
Revenue beat(12)5
Avg Revenue beat(12)-1.19%
Revenue beat(16)8
Avg Revenue beat(16)-0.48%
PT rev (1m)-2.04%
PT rev (3m)28.4%
EPS NQ rev (1m)1.77%
EPS NQ rev (3m)15.72%
EPS NY rev (1m)-0.25%
EPS NY rev (3m)6.18%
Revenue NQ rev (1m)-0.05%
Revenue NQ rev (3m)6.44%
Revenue NY rev (1m)-1.06%
Revenue NY rev (3m)1.76%
Valuation
Industry RankSector Rank
PE 16.94
Fwd PE 15.83
P/S 2.39
P/FCF 34.06
P/OCF 8.19
P/B 1.73
P/tB 1.73
EV/EBITDA 4.61
EPS(TTM)2.03
EY5.9%
EPS(NY)2.17
Fwd EY6.32%
FCF(TTM)1.01
FCFY2.94%
OCF(TTM)4.2
OCFY12.21%
SpS14.39
BVpS19.89
TBVpS19.89
PEG (NY)2.41
PEG (5Y)0.55
Graham Number30.14
Profitability
Industry RankSector Rank
ROA 7.56%
ROE 11.62%
ROCE 12.7%
ROIC 10.17%
ROICexc 15.86%
ROICexgc 15.86%
OM 24.51%
PM (TTM) 16.06%
GM 35.3%
FCFM 7.01%
ROA(3y)7.8%
ROA(5y)7.34%
ROE(3y)12.05%
ROE(5y)11.43%
ROIC(3y)12.29%
ROIC(5y)11.75%
ROICexc(3y)20.09%
ROICexc(5y)18.3%
ROICexgc(3y)20.09%
ROICexgc(5y)18.3%
ROCE(3y)15.36%
ROCE(5y)14.68%
ROICexgc growth 3Y-10.62%
ROICexgc growth 5Y18.95%
ROICexc growth 3Y-10.62%
ROICexc growth 5Y19.05%
OM growth 3Y-1.57%
OM growth 5Y18.52%
PM growth 3Y3.68%
PM growth 5Y23.71%
GM growth 3Y-0.36%
GM growth 5Y9.83%
F-Score6
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 242.55%
Cap/Sales 22.16%
Interest Coverage 250
Cash Conversion 86.71%
Profit Quality 43.67%
Current Ratio 5.37
Quick Ratio 4.99
Altman-Z 3.84
F-Score6
WACC10.98%
ROIC/WACC0.93
Cap/Depr(3y)187.79%
Cap/Depr(5y)164.84%
Cap/Sales(3y)17.34%
Cap/Sales(5y)16.42%
Profit Quality(3y)93.18%
Profit Quality(5y)98.28%
High Growth Momentum
Growth
EPS 1Y (TTM)2.53%
EPS 3Y0.83%
EPS 5Y30.81%
EPS Q2Q%1.69%
EPS Next Y7.02%
EPS Next 2Y5.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.04%
Revenue growth 3Y0.99%
Revenue growth 5Y6.85%
Sales Q2Q%-3.08%
Revenue Next Year5.7%
Revenue Next 2Y6.23%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.03%
EBIT growth 3Y-0.59%
EBIT growth 5Y26.64%
EBIT Next Year48.72%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-54.32%
FCF growth 3Y-28.46%
FCF growth 5Y-3.72%
OCF growth 1Y-5.22%
OCF growth 3Y-3.44%
OCF growth 5Y11.62%

PHOTRONICS INC / PLAB FAQ

What is the fundamental rating for PLAB stock?

ChartMill assigns a fundamental rating of 6 / 10 to PLAB.


Can you provide the valuation status for PHOTRONICS INC?

ChartMill assigns a valuation rating of 6 / 10 to PHOTRONICS INC (PLAB). This can be considered as Fairly Valued.


How profitable is PHOTRONICS INC (PLAB) stock?

PHOTRONICS INC (PLAB) has a profitability rating of 7 / 10.


What is the valuation of PHOTRONICS INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for PHOTRONICS INC (PLAB) is 16.94 and the Price/Book (PB) ratio is 1.73.